The Technical Analyst
Select Language :
ImmunityBio, Inc. [IBRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

ImmunityBio, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

ImmunityBio, Inc. is listed at the  Exchange

6.64% $5.46

America/New_York / 27 mar 2024 @ 16:00


ImmunityBio, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3 679.78 mill
EPS: -1.150
P/E: -4.75
Earnings Date: May 08, 2024
SharesOutstanding: 673.95 mill
Avg Daily Volume: 3.99 mill
RATING 2024-03-27
C
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.75 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.81x
Company: PE -4.75 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-1.261
(-123.10%) $-6.72
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.97 - 5.95

( +/- 8.97%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-22 Simon Barry J. Buy 159 146 Stock Option (right to buy)
2024-02-22 Simon Barry J. Buy 45 731 Restricted Stock Units
2024-02-22 Lauer Regan J Buy 42 439 Stock Option (right to buy)
2024-02-22 Lauer Regan J Buy 12 195 Restricted Stock Units
2024-02-22 Sachs David C. Buy 424 390 Stock Option (right to buy)
INSIDER POWER
99.25
Last 97 transactions
Buy: 228 380 025 | Sell: 921 083

Forecast: 16:00 - $5.45

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $5.45
Forecast 2: 16:00 - $5.45
Forecast 3: 16:00 - $5.45
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.46 (6.64% )
Volume 5.12 mill
Avg. Vol. 3.99 mill
% of Avg. Vol 128.36 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for ImmunityBio, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for ImmunityBio, Inc.

RSI

Intraday RSI14 chart for ImmunityBio, Inc.

Last 10 Buy & Sell Signals For IBRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$4.27N/AActive
Profile picture for
            ImmunityBio, Inc.

IBRX

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Last 10 Buy Signals

Date Signal @
GOGL.OLMar 27 - 08:09NOK136.70
EQNR.OLMar 27 - 08:08NOK286.40
MULTI.OLMar 27 - 08:05NOK148.00
DNB.OLMar 27 - 08:05NOK215.10
MOWI.OLMar 27 - 08:08NOK198.95
CADLR.OLMar 27 - 08:05NOK53.10
CLUSDMar 28 - 04:46$81.67
NOD.OLMar 27 - 08:05NOK85.80
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.